Private Advisor »

Zentalis Pharmaceuticals shares owned by Private Advisor

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Private Advisor from 13F filings

Historical chart of Private Advisor investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Private Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Private Advisor

Quarter filed Position value Share count Share price at filing
2026-03-31 $74k 32k 2.34

More positions owned by Private Advisor

Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust State Street Spd (SPTM)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SPYG)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
J P Morgan Exchange Traded F Active Bond Etf (JBND)

View all positions for Private Advisor

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals